Cell therapy has great promise for treating gastrointestinal motility disorders caused by intestinal nervous system (ENS) diseases. However, appropriate sources, other than enteric neural stem cells and human embryonic stem cells, are seldom reported. Here, we show that neural progenitors derived from the dorsal root ganglion (DRG) of EGFP mice survived, differentiated into enteric neurons and glia cells, migrated widely from the site of injection, and established neuron-muscle connections following transplantation into the distal colon of postnatal mice. The exogenous EGFPþ neurons were physiologically functional as shown by the activity of calcium imaging. This study shows that that other tissues besides the postnatal bowel harbor neural crest stem cells or neural progenitors that have the potential to differentiate into functional enteric neurons in vivo and can potentially be used for intestinal nerve regeneration. These DRG-derived neural progenitor cells may be a choice for cell therapy of ENS disease as an allograft. The new knowledge provided by our study is important for the development of neural crest stem cell and cell therapy for the treatment of intestinal neuropathy.
Introduction
The enteric nervous system (ENS) plays a significant role in regulating motility, secretion, and other gut functions 1 . The most common identifiable disorder of the ENS is Hirschsprung disease (HD), which occurs in 1 of every 5000 live births as a result of neural crest-derived precursor cells failing to colonize the gut during embryonic development 2 . Current therapy for HD is surgical resection of the aganglionic bowel or the region of the bowel affected by complications 3 , but few effective treatments are available for the acquired enteric neuropathies 4, 5 . Based on tremendous advances in regenerative medicine, stem cell-based replacement of defective or missing enteric neurons for HD treatment is a promising therapeutic tool to avoid surgery, optimize outcomes, and restore gut motility. Several candidate cells have been explored for ENS reconstruction, including the ENS itself, skinderived neural crest stem cells (NCSC), human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) [6] [7] [8] [9] [10] [11] [12] [13] .
The fetal and postnatal intestine from rodent and human is an attractive source from which to isolate neural progenitor cells (NPs) [14] [15] [16] [17] [18] [19] [20] [21] [22] . Notably, these neonatal enteric neural stem cells (ENSC) showed migration ability, and differentiate into neurons and glia cells following transplantation into the postnatal rodent gut 6, [23] [24] [25] . ENSC-expressing channelrhodopsin showed functional integration and innervation of the smooth muscle of the bowel wall following the transplantation into the bowel 26 . Fattahi et al. reported vagal neural crest lineage induction from hESCs, and further differentiation into ENS in vivo 13 . Although the question of bowel motility remained to be addressed 27 , the HD model mice had extended lifespans after cell transplantation.
To date, no other source of cells has been reported for ENS formation in the gut. Previous reports indicated that, according to the development principle, NCSCs were the source of ENS. Various sources of NCSCs have been identified; NCSCs can be derived from the embryonic sciatic nerve 28 and boundary cap 29 , the gut, skin 30, 31 , bone marrow 32 , and the dorsal root ganglia (DRG) 32, 33 of adult rodents. The NCSCs from different tissues share a common developmental origin with ENS. Considering the roles of NCSCs during embryonic development and neuropathies of the intestine, other NCSC-containing tissues might be potential cell sources for intestinal ENS regeneration. In the present study, we explored the differentiation potential of NCSC isolated from DRG in ENS in the postnatal colon. We also studied whether NCSC coming from DRGderived NCSC exhibit a similar potential for differentiation in the gut as the NCSC from intestine described in previous reports 23, 25 . Following transplantation into the postnatal colon of mice, the DRG-NPs survived, migrated, and differentiated into functional enteric neurons. The DRG-NPs also expressed mature presynaptic protein synaptophysin and closely associated with endogenous neurons and muscle. This study showed for the first time that NCSC from sources other than ENSCs and hESCs/iPSCs could generate functional enteric neuron in the postnatal gut, thus broadening the range of cell candidates for the anatomic and functional replacement of ENS cells. Our results also suggest that NCSCs from postnatal tissues besides the gut might still maintain their multipotency for ENS differentiation, independent of tissue source.
Materials and Methods

Experimental Animals
Wild-type C57BL/6 J and C57BL/6-Tg (CAG-EGFP) (average body weight 25 + 1.2 g for both male and female) were purchased from Model Animal Center of Nanjing University (Nanjing, China). Animal experiments were conducted according to the Guidelines of the Zhejiang University Laboratory Animal Center for the care and use of laboratory animals, and were approved by the Animal Care and Use Committee of the Medical School, Zhejiang University.
DRG NP Cell Generation, Derivation and Identification
Lumbar dorsal roots at the levels between L1 and L5 were carefully removed from C57BL/6-Tg (CAG-EGFP) mice at postnatal day 7 and placed in cold Dulbecco's modified eagle's medium (DMEM) with 1% penicillin/streptomycin (Gibco, Grand Island, NY, USA). DRG-NCSCs were generated as previously described with some modifications 34 . Each dorsal root was minced with scissors into small pieces for explant culture. The explants were harvested and seeded in 24-well plates coated with collagen (Gibco, 5 mg/ cm 2 ) in primary medium of DMEM: F12 (Gibco), containing N2 (100Â, Gibco), B27(50Â, Gibco), basic fibroblast growth factor (bFGF, 20 ng/ml, Peprotech, Rocky Hill, NJ, USA) and epidermal growth factor (EGF, 20 ng/ml, Peprotech). In DRG explant cultures, cells with a triangular shape migrated out of the explants and formed a layer on the collagen after the first 1-2 days. The explant pieces were then picked up and attached to a fresh plate for another 1-2 days. Each explant was cultured on a fresh plate two or three times. Cells migrating out from the explants were proliferated in neural progenitor proliferation medium, which was made up in 500 ml batches containing 432 ml of DMEM: F12, 50 ml of Probumin (20% vol/vol stock solution, Millipore, Bedford, MA, USA), 5 ml of penicillin/streptomycin (Gibco), 5 ml of L-alanyl-L-glutamine (Cellgro, Lincoln, NE, USA), 5 ml of MEM non-essential amino acids (Cellgro), 0.5 ml of trace elements A (Cellgro), 0.5 ml of trace elements B (Cellgro), 0.5 ml of trace elements C (Cellgro), 0.9 ml of 2-mercaptoethanol (Invitrogen), transferrin (10 mg/ml, Invitrogen), (þ) sodium L-ascorbate (50 mg/ml, Sigma), Heregulin B-1 (10 ng/ml, Peprotech), LONGR3 IGF-I (200 ng/ ml, Sigma) and bFGF (8 ng/ml, Peprotech) 35 . Cells were detached and formed spherical aggregates after they were transferred to low-attachment plates. Half of the medium was changed every 3 days.
Differentiation
To assess the ability of cells to differentiate into a neural lineage, the differentiation method from Lee et.al was used 36 . Briefly, DRG-NCSCs at passage 2 were chosen for neuron and glia differentiation analysis and seeded at 5000 cells/cm 2 on coverslips coated with poly-ornithine (0.01%, 1:5 dilutions, Sigma, St. Louis, MO, USA)/fibronectin (25 mg/ml) in 24-well plates. For neuron differentiation, the medium consisted of DMEM: F12 medium (1:1, Gibco), 2% B27 medium (Gibco), brain-derived neurotrophic factor (10 ng/ml, Peprotech), glial cell line-derived neurotrophic factor (10 ng/ml, Peprotech), nerve growth factor (10 ng/ ml, Peprotech), neurotrophin-3 (10 ng/ml, Peprotech), ascorbic acid (200 mM, Sigma) and cAMP (0.5 mM, Sigma). For glia differentiation, the medium consisted of DMEM: F12 medium (Gibco), N2, B27 medium (Gibco), bFGF (10 ng/ ml, Peprotech), EGF (10 ng/ml, Peprotech) and 5% fetal bovine serum (FBS, Gibco). DRG-NPs were cultured for 2-3 weeks, and the medium was changed every 2-3 days. Differentiated cells were analyzed by assessing the expression of neural and glia markers by immunocytochemistry.
Transplantation
The surgery of transplantation was performed according to a previous report 23 . Briefly, DRG-derived neurospheres at passage 2 were transplanted into the distal intestine of 6-to 8-week-old C57BL/6 J wild-type mice. Animals were anesthetized by the injection of 200 ml 5% chloral hydrate solution (RWD Life Science, San Diego, CA, USA). A small abdominal incision was made, and the distal colon was exposed and exteriorized. A total of 6 ml of neurospheres (1.0 Â 10 5 cells/ml) with a mean diameter of about 40 mm for transplantation in DMEM: F12 medium with 50% Matrigel (BD Biosciences, Franklin Lakes, NJ, USA) were injected into the external muscle layer of the distal colon with a glass needle at three sites, and the injection sites were marked with 7/0 Nylon. After 10 min, the distal colon was returned, and then the abdominal wall and skin was seamed with 7-0 suture. Animals were injected with cefoperazone and sulbactam sodium 0.5 mg per gram of body weight (0.5 mg/g) postoperatively. The recipient mice were immunosuppressed by daily injections of cyclosporine 10 mg per gram of body weight (10 mg/g, Sigma). At 1, 2, 3, 4, 6, 7 or 8 weeks after surgery, the mice were sacrificed and the tissue was collected for histological analysis.
Tissue Preparation
For cryosections, the distal colon was opened along the mesenteric border, pinned, stretched on Sylgard coated dishes, fixed in 4% paraformaldehyde (PFA), and dehydrated in 30% sucrose with phosphate buffer saline (PBS), and then transferred to an O.C.T. cryomold (Tissue-Tek, Torrance, CA, USA). Frozen sections (12 mm thick) were cut transversely or longitudinally on a cryostat.
Immunohistochemistry
Immunostaining was performed on primary monolayer cells, spheres, differentiated cells and cryosections of gut samples. Cultured cells or tissue sections were fixed with 4% PFA for 15 min at room temperature, rinsed three times with PBS, and then exposed to blocking solution (PBS containing 5% serum of the same origin as the secondary antibody and 0.2% Triton X-100) for 30 min at room temperature followed by overnight incubation at 4 C with the primary antibodies in blocking solution, and subsequent incubation for 1 h with secondary antibodies at room temperature. Primary and second antibody information is listed in Table 1 .
Measurement of Cell Fiber Length, Differentiation and Statistical Analysis
To determine the fiber length of cells derived from DRG-NCSC-derived neurospheres implanted in the distal colon, a z-series of images was obtained on a Nikon A1 confocal microscope. The images were projected, and the fiber length 
Ca 2þ Imaging
Transplanted animals were euthanized by 200 ml chloral hydrate (10%). For Ca 2þ imaging, the protocol used was that of Fried et al. with minor revision 37 . Intestinal segments were removed and immediately placed in the medium prepared as DMEM: F12 with 3 mM nicardipine hydrochloride and 1 mM scopolamine hydrochloride (hereafter referred to as "Medium") in a dish on ice. The region of the distal colon owning EGFP þ transplanted cells was incised along the mesenteric border and pinned flat under light tension with the mucosa side up in medium with a silicone elastomer (Sylgard 184, Dow Corning, Midland, MI, USA). The mucosal and submucosal layers were carefully dissected using fine forceps. After washing with medium three times, tissue preparations were incubated with 4 mM Rhod-2 (Life Technologies, Thermo Fisher Scientific, Waltham, MA, USA) in loading solution (3 ml medium with 2.4 ml of a 250 mM probenecid stock and 1.5 ml of 4 mM Rhod-2 stock) for 30 min in a dark incubator at 37 C. After loading, tissues were transferred to a recording chamber and mounted on an inverted confocal laser-scanning microscope. Rhod-2 was excited at 552 nm, and its fluorescence emission was measured at 581 nm using a 10Â objective. Recordings were made at room temperature under constant local perfusion (2 ml/min) with modified Krebs buffer (121 mM NaCl, 5.9 mM KCl, 2.5 mM CaCl 2 , 1.2 mM MgCl 2 , 1.2 mM NaH 2 PO 4 , 10 mM HEPES, 21.2 mM NaHCO 3 , 1 mM pyruvic acid, and 8 mM glucose with pH adjusted to 7.4 with NaOH). High K þ (70 mM) was used for stimulating the cells and image sequences were captured at a frequency of one image every 2s. After recording, the time-lapse movie of the experiment was viewed and regions of interest (ROIs) were selected. The fluorescence intensities (F) of the ROIs were compared with the initial baseline fluorescence value (F0). Changes in normalized fluorescence intensity (DF/F0) were directly proportional to changes in Ca 2þ concentration.
Results
In Vitro Derivation and Characterization of Transplantable NCSC Progenitors from the Postnatal DRG
It has been demonstrated that adult DRGs harbor NCSCs and that these NCSCs could be derived from DRG explant culture 33, 38 . Here, we isolated these NCSCs from postnatal C57BL/6-Tg (CAG-EGFP þ ) mice using a previously published protocol with some modifications 38 . Because of the high migratory ability of NCSCs 39 , NCSCs were the first type of cells to migrate out of DRG explants after the explants had attached to the plate. Cells migrating out from the DRG formed a dense layer on the collagen after 1 week. Other kinds of cells also eventually migrated out the explants during the 1-week process of explant culture; thus, to optimize the purity and reduce the proportion of non-NCSCs within the emigrated cells, every piece of DRG was transferred to another well or plate after 1-2 days of attachment (Fig 1 B, C) . Each piece of explant was used for attachment no more than three times, and cells migrating out from the DRG were used for further proliferation in NP proliferation medium. The selected cells were then continuously cultured as a monolayer, or as spheres that were spontaneously formed in passage 2 on low-attachment plates prior to transplantation (Fig 1D, E) . The whole process is illustrated in Fig 1A. The next step was to confirm the identity of cells migrating out from the DRG. The lowaffinity neurotrophin receptor (P75)-a transmembrane glycoprotein-is expressed in enteric NCSCs and glial cells 40 and has been used as a selection marker for successfully isolating NCSCs from the gut tissue of mice and humans [41] [42] [43] . In combination with the NCSCs marker Sox10 and neural stem cell (NSC) marker Nestin, P75 was used to identify the NCSCs from the DRG. Cells migrating out from the DRG were cultured on fibronectin-coated coverslips for 2 days, fixed, and analyzed by immunocytochemistry. To monitor the behavior in vivo, these cells were derived from mice expressing enhanced green fluorescent protein (EGFP) (Fig 1F, J) , and most of them were positive for the three NCSC markers, P75 (87.4% + 6.9%, n ¼ 3), Sox10 (79.7% + 6.8%, n ¼ 3) and Nestin (83.6% + 1.4%, n ¼ 3) (Fig 1F-L and M) . To ensure a sufficient number of cells for transplantation, migrated cells at passage 2 or passage 3 were allowed to proliferate before the transplantation. To demonstrate that these cells still maintained NCSC markers after a period of time in proliferation medium, immunostaining of DRG-derived cells in passage 2 spheres showed that most of these cells expressed the NSC marker Nestin (79.3% + 10.7%, n ¼ 3), the NCSC markers Sox10 (85.4% + 8.6%, n ¼ 3) and P75 (87.6% + 6.4%, n ¼ 3) (Fig S1 A-C, E) . The proliferative characteristics of the cells were demonstrated by the positive immunostaining of Ki67 (passage 5 as a monolayer, Ki67 þ cells accounted for 67.7% + 8.7% of cells, n ¼ 3) (Fig S1 C-E) and by the growth curves of cells at passage 1 and passage 5 (Fig S1 F) . The growth curves indicated that the proliferative ability slightly decreased after four passages.
NPs Can Be Induced from DRG-Derived NCSCs
To explore the differentiation ability of DRG-NCSCs into peripheral neurons and glia cells, DRG-derived cells at passage 2 were transferred onto poly-ornithine/fibronectincoated coverslips in neural differentiation medium for 10-14 days. Besides the pan-neuronal markers TuJ1 (b-tubulin), NF200, and PGP9.5, the peripheral neuron marker Peripherin and the enteric neural marker NOS (neuronal nitric oxide synthase, nNOS) were also detected on the DRG-derived cells (Fig 2 and Fig S2) . In glia differentiation medium, which consisted of N2, B27, bFGF, EGF, and 5% serum, most of the cells were TuJ1 þ (77.8% + 9.7%, n ¼ 3) and a smaller proportion showed the expression of the glia cell marker S100b (36.7% + 11.2%, n ¼ 3) (Fig 2D) , which indicated that the DRG-derived NCSCs were able to differentiate into peripheral neurons and glia cells, and could be induced to become NPs after two passages.
DRG-Derived EGFP-Expressing NPs Migrated and Projected Nerve Fibers Following Transplantation into the Postnatal Mouse Hindgut
To determine whether DRG-NPs populate in the postnatal mouse colon, DRG-NPs harvested from EGFP þ mice were surgically implanted into the external muscle layer of the distal colon of 6-to 8-week-old C57BL/6 J mice. The cells used for transplantation were in short-term culture for no more than three passages, because cells in mid-term and long-term culture have been reported to often differentiate into smooth muscle cells after growth factors are withdrawn 38 . The recipient colons were examined at 1, 2, 3, 4, 7, and 8 weeks after surgery with 6-7 mice at each time point. Exogenous cells and neurites survived in 39 of 40 transplanted mouse colons, in which 6 of 6 were found available for 8 weeks following transplantation.
We first explored the ability of DRG-NPs to colonize in the wild type postnatal mouse hindgut. EGFP þ cells existed in the cryosections of the host gut 1-8 weeks after transplantation. This proved that exogenous DRG-NPs survived and engrafted in the host gut (Fig 3A1-E) . Following the cell injection, numerous EGFP þ cells migrated away from the injection sites without specific direction. The migration distance exceeded 2.0 mm as shown in the figure, which was photographed and stitched together in the same plane (Fig.  3A2-A4) , and the maximum distance of the observed migration in different planes in the colon was >3.5 mm. We observed EGFP þ distribution throughout the distal gut with many cells exhibiting TuJ1 staining (Fig 3A2-E, Fig 4 A-D,  Fig S3 A-D) . These results indicated that DRG-derived EGFP þ NPs were competent for colonization of the gut tube and contributed to enteric neurogenesis.
Many EGFP þ projections diffused from exogenous cell bodies in different directions. Fluorescence imaging showed that most of the EGFP þ cells exhibited neuron-like morphologies and showed fiber extension (Fig 3A1-A4 ). The fibers elongated over time after transplantation, and the average fiber length was 0.17mm + 0.018 mm at 1 week, 0.23 mm + 0.01 mm at 3 weeks, and 0.34 mm + 0.04 mm at 7 weeks after transplantation (n ¼ 3 experiments). These results showed that the DRG-NPs survived, migrated, and fibers extended from the transplantation site following transplantation into the postnatal distal gut.
DRG-Derived NPs Differentiated into Neurons and Glial Cells in the Distal Gut
We next examined whether exogenous neurons and glial cells were present after the transplantation of EGFP þ DRG-NPs. We found that transplanted DRG-NPs differentiated into neurons based on the immuno-staining of the panneuronal cell marker TuJ1 in the longitudinal and transverse section, and glial cells indicated by the staining of glial cell marker S100b in the longitudinal section. Double immunofluorescence staining of grafted EGFP þ cells showed the colocalization of EGFP with TuJ1 and S100b individually (Fig  4 A-H, Fig S3 A-D) . Four weeks after transplantation Tuj1-expressing cells accounted for 86% + 5% of all cells (n ¼ 4 experiments). The result showed that most of the grafted cells differentiated into neurons, while some DRG-derived cells differentiated into glia cells (8% + 1.5%, n ¼ 3 experiments) (Fig S3 E) . These results suggested that engrafted DRG-NPs survived and differentiated in the distal colon of recipient mice.
Some exogenous clusters similar to enteric ganglia were found a distance away from the transplantation site 4 weeks after transplantation (Fig 4A-D) . Most of cells in the ganglion-like clusters are TuJ1 þ cells (Fig 4A-C) . It showed that the transplanted DRG-NPs were capable of forming the ganglion-like clusters in the colon.
DRG-Derived NPs Differentiated into Neurons with Appropriate Enteric Subtypes
There are numerous types of neurons in the ENS in mice 1 . We used published markers (nNOS, VIP and TH) to identify the neurons and enteric subtype neurons in the mice 4 weeks after transplantation 23 . Some EGFP þ neurons and fibers showed positive immunostaining to nNOS (Fig 5A-D) , vasoactive intestinal polypeptide (VIP) (Fig 5E-H) , and tyrosine hydroxylase (TH) (Fig 5I-K) . Grafted cells differentiated into different proportions of enteric subtypes as indicated by the presence of nNOS (26% + 6%, n ¼ 4 experiments), TH (12% + 3%, n ¼ 4 experiments) and VIP (21% + 5%, n ¼ 3 experiments) (Fig 5 L) . These data showed that the niche in the postnatal colon supported the differentiation of enteric subtype neuron with relative neurochemical marker.
DRG-NPs colonized the appropriate gut layers, and the mature presynaptic protein synaptophysin expressed in conjunction of exogenous and endogenous cells.
To explore the location in the gut wall where EGFP þ cells and fibers migrated, we examined the longitudinal and transverse frozen sections from post-surgery mice using confocal microscopy. The staining of the transverse section at 4 weeks after transplantation showed that transplanted EGFP þ cells were present mainly in the inter-myenteric layer of the intestine (Fig 3 C-E, Fig 5 I-K, Fig 6 A-D) . Graft-derived TuJ1 þ cells were present in the group of cells that remained in the longitudinal muscle, circular muscle, and mucosa of the intestine (Fig 3 C-E, Fig S3 A-D) . Furthermore, exogenous TH þ cells were detected in the longitudinal muscle and circular muscle layer of the intestine (Fig 5 I-K) .
Graft-derived neurites were found to exist in the longitudinal and circular muscle layers, and these neurites closely associated with endogenous neurons and muscles of the recipient animal as shown by synaptophysin staining (Fig 6 A-D; Fig S4 A-H) . The layers where exogenous cells located were alike to the endogenous neurons' location. It showed that EGFP þ neurons localized in the submucosa, and neurites were similarly found in the mucosa as endogenous fibers. These results indicated that DRG-derived cells and neurites expressed the mature presynaptic protein synaptophysin with endogenous neurons and muscles in these layers.
Transplanted DRG-NPs Differentiated into Neurons with Active Electrophysiology
In order to test whether transplanted neurons were electrophysiologically functional, in situ Ca 2þ imaging was performed 4-6 weeks after DRG-NP implantation. We determined the changes in Ca 2þ concentration upon a brief high Kþ exposure (70 mM, 15 s) through a continuous perfusion system (2 ml min -1 ). Grafted neurons responded with a rise in Ca 2þ concentration (2 + 0.55 F/F0, cells from the region of interest) (Fig 7A-D) . These results showed that the surroundings of the postnatal colon support that DRG-NPs differentiate into functional neurons with active electrophysiology.
Discussion
The neural crest originates from the neural folds during vertebrate development. Neural crest cells migrate from the dorsal neural tube to different locations including the gut, dorsal root ganglion, heart, face, skin, etc., where they differentiate into different kinds of cells, including peripheral nervous systems including ENS and non-peripheral nervous systems containing smooth muscle cells, bone, and cartilage cells. Based on the developmental principle, NCSCs might be cell sources for gut neuropathy therapy. We thus hypothesized that those postnatal tissue-derived NCSCs from tissues other than the gut have the ability to reconstruct ENS tissues in vivo. DRG-derived NCSCs were chosen to explore this possibility based on the potential for multilineage differentiation into neurons, glial cells, myofibroblasts, and pericytes 32, 38 . In spite of the possibility of DRG-NPs for ENS formation, considering previous reports on the low proportion of neuron differentiation for DRG-derived NCSC 33, 38 , we optimized the generation of NPs from the isolated postnatal DRG, and these cells exhibited high rates of differentiation into peripheral neurons in vitro and in vivo. We were able to direct a high proportion of neuron differentiation as opposed to glia cells. The in vitro expression pattern of DRG-NPs was different from previous studies, which showed the inclined differentiation into Schwann cells 33, 38 . At 3 weeks after transplantation, the majority of graft cells were TuJ1 þ and a small portion were S100b þ cells. The colon circumstances redirect adult DRG-NPs into more subtypes of enteric neurons following transplantation compared with the environment in vitro. These findings showed that most DRG-NPs differentiated into neurons and to a lesser extent into glial cells. In general, our data indicated that DRG-NPs effectively differentiated into neurons both in vitro and in vivo.
The neural stem cells/progenitors used for HD disease treatment should meet the following requirements, including migration, differentiation into enteric subtype neurons, integration into the local neural circuitry with the appropriate neurochemical and electrophysiological characteristics following transplantation into the postnatal colon 23 . In the present study, we showed that NPs, which were generated from DRG-NCSCs, survived, migrated, integrated, and differentiated into glial cells as well as diverse subtype neurons with similar neurochemical and electrophysiological properties to endogenous enteric neurons.
The gut contains a range of enteric subtype neurons, which are pivotal in controlling muscle contractile activity 44, 45 . In this study, exogenous DRG-NPs differentiated into neurons alike to normal enteric neurons in terms of morphological and neurochemical markers such as nNOS, VIP, and TH 23, 46, 47 . The neural circuitry in charge of motility requires accurate connection among different functional neurons and muscles. Our findings indicated that exogenous DRG-NP cells were distributed in layers similar to those of the NCSC derivatives that act during normal development. We observed that DRG-NP-derived EGFP þ neurons projected into the appropriate gut layer and expressed the mature presynaptic protein synaptophysin. It has been reported that enteric NPs are capable of differentiating into neurons with electrophysiological activity and are possibly functional in the gut 23, 25 . Our results showed that exogenous neurons were also capable of electrophysiological activity after transplantation in vivo.
It was reported that some of the endogenous sensory neurons were found in the submucosal plexus 48, 49 . Submucosal ganglia may be very important for the gut's normal function. In our study, graft-derived cells and fibers were also observed in the submucosa. This was slightly different from previous work that used ENSCs for colon transplantation 23 . One of the principle challenges for stem cell therapy in bowel motility is to decide which source of stem cells is most efficacious. However, it is currently difficult to define the best candidate. Each candidate of stem/progenitor cells possesses certain disadvantages and advantages, and the principles for utilizing each one depends on the desired applications and outcomes. The most attractive characteristics of enteric neural stem cells are the avoidance of immune suppression and ethical issues because the cells are patientderived autologous cells. However, the limited quantity and limited ability in proliferation of these cells might be a major hurdle for clinical use 16, 17 . Another issue is that the congenital defect gene in transplanted cells of HD patients has to be corrected prior to autologous cells transplantation, and gene correction is difficult because of the limited proliferation of enteric NCSC. Human ESCs are another promising cell source for bowel motility disease, and they could potentially provide the huge numbers of human enteric neurons needed for clinical use 13 . Nevertheless, some questions remain to be answered before human ESCs/iPSCs can be used for clinical therapy, especially questions related to bowel motility evaluation and safety concerns 50, 51 . Future studies investigating these issues should not be limited to any single population of cells because information provided from the research of individual cell type will benefit the HD field as a whole 27 . Considering the therapeutic purpose and their confined location, exploitation of DRG-NPs for autograft seems impractical. Much research has suggested that fetal stem cells have greater multilineage capacity than adult stem cells, and hence have greater potential for clinical use. Fetal grafts might be integrated into the host with lower immunogenicity by the host, or under HLA match 52 . Considering the limited proliferation of autologous cells and the huge demand for cell numbers in cell therapy of ENS disease, our present findings suggest that isolation of human DRG-NPCs from postmortem tissues, surgical specimens, or aborted fetus might be attempted as a way to produce neural progenitors for allograft 53 for clinical use under conditions where HLAs match.
This study may broaden the range of candidates for cell replacement of ENS cells. Our data showed that NCSC from DRG, which harbor NCSCs, have similar differentiation potential as functional enteric neurons in vivo as enteric NCSC. It can be presumed that other tissues where NCSCs are maintained, such as hair follicles, skin, and teeth, might also be reasonable sources of cells for enteric regeneration. Thus, our study suggests important avenues for future studies into the development of cell therapies for treating intestine neuropathies.
Conclusion
On the whole, DRG-neural progenitor cells migrated and differentiated into enteric neuron subtypes and glia cells, established close connections with inherent enteric neurons and smooth muscles with physiological functions, and integrated into the neuronal circuitry in the postnatal gut. This suggested the potential for stem cells from allografts such as fetal or postmortem tissues to replace diseased or missing ENS in HD under HLA match. The function of the colon in the HD model mice following DRG-NP transplantation requires further investigation.
